FMO5 and hypertensive disorder: Using molecular markers such as eNOS, mineralocorticoid receptor (MR) signaling, SOD, and NADPH oxidase is a powerful way to mechanistically support observations of impaired vasorelaxation in experimental hypertension, especially in the context of dietary potassium interventions.